Zoonotic Disease Treatment Market

Zoonotic Disease Treatment Market Overview

The global zoonotic disease treatment market was valued at around US$ 36.9 Bn at the end of 2021. The market is projected to register a 5.9% CAGR and top a valuation of US$ 69.2 Bn by 2032.

“Crowded settings, poor hygiene, fluctuating temperatures and habitats, livestock farming, and a lack of awareness are foreseen aspects supporting the growth of the zoonotic disease treatment market.”

Animals often carry dangerous pathogens that can infect humans and produce zoonotic diseases, also called zoonoses. A sort of unexpected illness known as zoonosis is spread from both animals to humans and from humans to animals. Zoonotic diseases are brought on by pathogenic microorganisms such as bacteria, fungi, parasites, and viruses.

Mild to severe illnesses, even deaths can be led on by these infections in both humans and animals. Some zoonotic diseases include tuberculosis, rabies, hepatitis, and relapsing fever. Depending on the zoonotic disease, animals can occasionally seem healthy even when they are harboring pathogens that can make people sick.

What are the Major Drivers Boosting the Demand for Zoonotic Disease Treatment Market?

Population growth, migration, and rapid urbanizationare all factors that could lead to the emergence of new zoonotic diseases in the future. Due to market and production procedures for live food animals, people in urban regions are less familiar with dealing with animals than those in rural settings. The urban population may also reside in overcrowded conditions that aid in the spread of disease.

Increased demand for animal proteins is probably going to result in increased consumption of animal fats, which is going to fuel the market for zoonotic disease treatment. With millions of households owning one or more pets for companionship and entertainment. However, the possibility that some animals may carry pathogens that might infect humans when in contact is anticipated to drive the market for the same.

Which Region Shows Strong Growth Potential in the Zoonotic Disease Treatment Market?

The zoonotic disease treatment market is broadly divided into seven major regions, North America, Latin America, Europe, East Asia, South Asia, Oceania, and the Middle East and Africa.

North America is the leading region in the global zoonotic disease treatment market owing to the rising population, higher rate of immigration, and rapid urbanization.

Apart from North America, the European zoonotic disease treatment market is also expected to display lucrative growth in the projected years due to the extensive livestock farming and increased consumption of animal fat in country places.

The East Asian region is predicted to show lucrative growth owing to a lack of access to safe drinking water and adequate sanitation services, which could contribute to the development of zoonotic diseases.

Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

Who are the Key Players in the Zoonotic Disease Treatment Market?

Cadila Healthcare Ltd, AstraZeneca plc, F. Hoffmann-La Roche AG, GlaxoSmithKline plc, Johnson & Johnson, Pfizer Inc., Novartis International AG, Sanofi S.A., BioCryst Pharmaceuticals, Inc, Sun Pharmaceuticals Industries, Ltd.

Scope of Report

Become a MarketNgage Insider

A unified Market Research Subscription Platform, built for today's disparate research needs.

Sign-Up

Key Segments Covered in the Zoonotic Disease Treatment Market Report

By Disease Type:

• Rabies
• Hepatitis
• Tuberculosis
• Fever
• Others

By Drug Class:

• Antifungal
• Antibacterial
• Antibiotic
• Others

By End User:

• Hospitals
• Specialty Clinics
• Homecare
• Others

By Region:

• North America
• Latin America
• Europe
• East Asia
• South Asia & Pacific
• The Middle East and Africa (MEA)